Body fluid and electrolyte balance during estrogen therapy of prostatic cancer.
D000450:Aldosterone / Q000652:urine; D000804:Angiotensin II / Q000097:blood; D001810:Blood Volume / Q000187:drug effects; D001835:Body Weight / Q000187:drug effects; D002712:Chlorides / Q000097:blood / Q000652:urine; D004054:Diethylstilbestrol / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use; D004231:Diuresis / Q000187:drug effects; D006321:Heart / Q000187:drug effects; D006801:Humans; D008297:Male; D009318:Natriuresis / Q000187:drug effects; D011188:Potassium / Q000097:blood / Q000652:urine; D011471:Prostatic Neoplasms / Q000188:drug therapy*; D012964:Sodium / Q000097:blood; D014882:Water-Electrolyte Balance / Q000187:drug effects*
D002712:Chlorides; D000804:Angiotensin II; D000450:Aldosterone; D004054:Diethylstilbestrol; D012964:Sodium; D011188:Potassium